Cooperation between HMGA1 and HIF-1 contributes to hypoxia-induced VEGF and visfatin gene expression in 3T3-L1 adipocytes

Frontiers in Endocrinology

Volumn 7, Issue , 2016, Pages 1-9

  Messineo, Sebastiano ^a   Laria, Anna Elisa ^a   Arcidiacono, Biagio ^a   Chiefari, Eusebio ^a   Huertas, Raúl M Luque ^b   Foti, Daniela P ^a   Brunetti, Antonio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

Adipocytes; Gene transcription regulation; HIF 1; HMGA1; Hypoxia; Obesity; VEGF; Visfatin

Indexed keywords

HIGH MOBILITY GROUP A PROTEIN; HYPOXIA INDUCIBLE FACTOR 1; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; SMALL INTERFERING RNA; VASCULOTROPIN;

ADIPOCYTE; ARTICLE; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; GENE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYPOXIA; LUCIFERASE ASSAY; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSIENT TRANSFECTION; VEGF GENE; WESTERN BLOTTING;

EID: 84980343910     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2016.00073     Document Type: Article

References (59)

1. Kopelman PG. Obesity as a medical problem. Nature (2000) 404(6778):635-43.
2. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser (2000) 894:i-xii,1-253.
3. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab (2000) 11(8):327-32. doi:10.1016/S1043-2760(00)00301-5.
4. Fasshauer M, Bluher M. Adipokines in health and disease. Trends Pharmacol Sci (2015) 36(7):461-70. doi:10.1016/j.tips.2015.04.014.
5. Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest (2011) 121(6):2111-7. doi:10.1172/JC157132.
6. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitasawa R, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest (2006) 116(6):1494-505. doi: 10.1172/JC126498.
7. Chen XH, Zhao YP, Xue M, Ji CB, Gao CL, Zhu JG, et al. TNF-alpha induces mitocondrial dysfunction in 3T3-L1 adipocytes. Mol Cell Endocrinol (2010) 328(1-2):63-9. doi:10.1016/j.mce.2010.07.005.
8. Kabon B, Nagele A, Reddy D, Eagon C, Fleshman JW, Sessler DI, et al. Obesity decreases perioperative tissue oxygenation. Anesthesiology (2004) 100(2):274-80. doi:10.1097/00000542-200402000-00015.
9. Trayhurn P. Hypoxia and adipose tissue function and dysfunction in obesity. Physiol Rev (2013) 93(1):1-21. doi:10.1152/physrev.00017.2012.
10. Lin Q, Yun Z. The hypoxia-inducible factor pathway in adipocytes: the role of HIF-2 in adipose inflammation and hypertrophic cardiomyopathy. Front Endocrinol (2015) 6:36. doi:10.3389/fendo.2015.00039.
11. Goossens GH, Blaak EE. Adipose tissue dysfunction and impaired metabolic health in human obesity: a matter of oxygen? Front Endocrinol (2015) 6:55. doi:10.3389/fendo.2015.00055.
12. Ichiki T, Sunagawa K. Novel roles of hypoxia response system in glucose metabolism and obesity. Trends Cardiovasc Med (2014) 24(5): 197-201. doi:10.1016/j.tcm.2014.03.004.
13. Semenza GL. Oxygen sensing, homeostasis, and disease. N Engl J Med (2011) 365(6):537-47. doi:10.1056/NEJMra1011165.
14. Palazon A, Goldrath AW, Nizet V, Johnson RS. HIF transcription factors, inflammation, and immunity. Immunity (2014) 41(4):518-28. doi: 10.1016/j. immuni.2014.09.008.
15. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA (1995) 92(12):5510-4. doi:10.1073/pnas.92.12.5510.
16. Salceda S, Caro J. Hypoxia-inducible factor 1a (HIF-1a) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem (1997) 272(36):22642-7. doi:10.1074/jbc.272.36.22642.
17. Semenza GL. Life with oxygen. Science (2007) 318(5847):62-4. doi:10.1126/science.1147949.
18. Brocato J, Chervona Y, Costa M. Molecular responses to hypoxia-inducible factor 1a and beyond. Mol Pharmacol (2014) 85(5):651-7. doi:10.1124/mol.113.089623.
19. Dehne N, Brüne B. HIF-1 in the inflammatory microenvironment. Exp Cell Res (2009) 315(11):1791-7. doi:10.1016/j.yexcr.2009.03.019.
20. Halberg N, Khan T, Trujillo ME, Wernstedt-Asterholm I, Attie AD, Sherwani S, et al. Hypoxia-Inducible Factor 1a induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol (2009) 29(6):4467-83. doi: 10.1128/MCB.00192-09.
21. Van Uden P, Kenneth NS, Rocha S. Regulation of hypoxia-inducible factor-1alpha by NF-kappaB. Biochem J (2008) 412(3):477-84. doi:10.1042/BJ20080476.
22. Chou YT, Zhan G, Zhu Y, Fenik P, Panossian L, Li Y, et al. C/EBP homologous binding protein (CHOP) underlies neural injury in sleep apnoea model. Sleep (2013) 36(4):481-92. doi:10.5665/sleep.2528.
23. Ruas JL, Poellinger L, Pereira T. Functional analysis of hypoxia-inducible factor-1 alpha-mediated transactivation. Identification of amino acid residues critical for transcriptional activation and/or interaction with CREB-binding protein. J Biol Chem (2002) 277(41):38723-30. doi:10.1074/jbc.M205051200.
24. Reeves R, Beckerbauer L. HMGI/Y proteins: flexible regulators of transcription and chromatin structure. Biochim Biophys Acta (2001) 1519(1-2):13-29.
25. Liu F, Chau KY, Arlotta P, Ono SJ. The HMGI proteins: dynamic roles in gene activation, development, and tumorigenesis. Immunol Res (2001) 24(1):13-29. doi:10.1385/IR:24:1:13.
26. Arnoldo L, Sgarra R, Chiefari E, Iiritano S, Arcidiacono B, Pegoraro S, et al. A novel mechanism of post-translational modulation of HMGA functions by the histone chaperone nucleophosmin. Sci Rep (2015) 5:8552. doi: 10.1038/srep08552.
27. Melillo RM, Pierantoni GM, Scala S, Battista S, Fedele M, Stella A, et al. Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation. Mol Cell Biol (2001) 21(7):2485-95. doi:10.1128/MCB.21.7.2485-2495.2001.
28. Schuldenfrei A, Belton A, Kowalski J, Talbot CC Jr, Di Cello F, Poh W, et al. HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis. BMC Genomics (2011) 12:549. doi:10.1186/1471-2164-12-549.
29. Foti D, Chiefari E, Fedele M, Iuliano R, Brunetti L, Paonessa F, et al. Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice. Nat Med (2005) 11(7):765-73. doi:10.1038/nm1254.
30. Chiefari E, Paonessa F, Iiritano S, Le Pera I, Palmieri D, Brunetti G, et al. The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis. BMC Biol (2009) 7:24. doi:10.1186/1741-7007-7-24.
31. Fedele M, Battista S, Manfioletti G, Croce CM, Giancotti V, Fusco A. Role of the high mobility group A proteins in human lipomas. Carcinogenesis (2001) 22(10):1583-91. doi:10.1093/carcin/22.10.1583.
32. Pierantoni GM, Battista S, Pentimalli F, Fedele M, Visone R, Federico A, et al. A truncated HMGA1 gene induces proliferation of the 3T3-L1 pre-adipocytic cells: a model of human lipomas. Carcinogenesis (2003) 24(12):1861-9. doi:10.1093/carcin/bgg149.
33. Arce-Cerezo A, García M, Rodríguez-Nuevo A, Crosa-Bonell M, Enguix N, Peró A, et al. HMGA1 overexpression in adipose tissue impairs adipogenesis and prevents diet-induced obesity and insulin resistance. Sci Rep (2015) 5:14487. doi:10.1038/srep14487.
34. Thanos D, Maniatis T. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell (1995) 83(7): 1091-100. doi:10.1016/0092-8674(95)90136-1.
35. Arcidiacono B, Iiritano S, Chiefari E, Brunetti FS, Gu G, Foti DP, et al. Cooperation between HMGA1, PDX-1, and MafA is essential for glucose-induced insulin transcription in pancreatic beta cells. Front Endocrinol (2014) 5:237. doi:10.3389/fendo.2014.00237.
36. Thanos D, Maniatis T. The high mobility group protein I(Y) is required for NF-kappa B-dependent virus induction of the human IFN-beta gene. Cell (1992) 71(5):777-89. doi:10.1016/0092-8674(92)90554-P.
37. Bloch M, Prock A, Paonessa F, Benz V, Bähr IN, Herbst L, et al. High-mobility group A1 protein: a new coregulator of peroxisome proliferator-activated receptor-y-mediated transrepression in the vasculature. Circ Res (2012) 110(3):394-405. doi:10.1161/CIRCRESAHA.111.253658.
38. Foti D, Iuliano R, Chiefari E, Brunetti A. A nucleoprotein complex containing Sp1, C/EBP beta, and HMGI-Y controls human insulin receptor gene transcription. Mol Cell Biol (2003) 23(8):2720-32. doi:10.1128/MCB.23. 8.2720-2732.2003.
39. Ji YS, Xu Q, Schmedtje JF Jr. Hypoxia induces high-mobility-group protein I(Y) and transcription of the cyclooxygenase-2 gene in human vascular endothelium. Circ Res (1998) 83(3):295-304. doi:10.1161/01.RES. 83.3.295.
40. Moussavi Nik SH, Newman M, Lardelli M. The response of HMGA1 to changes in oxygen availability is evolutionarily conserved. Exp Cell Res (2011) 317(11):1503-12. doi:10.1016/j.yexcr.2011.04.004.
41. Ferrara N. Vascular endothelial growth factor. Arterioscler Thromb Vasc Biol (2009) 29(6):789-91. doi:10.1161/ATVBAHA.108.179663.
42. Voros G, Maquoi E, Demeulemeester D, Clerx N, Collen D, Lijnen HR. Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology (2005) 146(10):4545-54. doi:10.1210/en.2005-0532.
43. Luk T, Malam Z, Marshall JC. Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity. J Leukoc Biol (2008) 83(4): 804-16. doi:10.1189/jlb.0807581.
44. Segawa K, Fukuhara A, Hosogai N, Morita K, Okuno Y, Tanaka M, et al. Visfatin in adipocytes is upregulated by hypoxia through HIF-1alpha- dependent mechanism. Biochem Biophys Res Commun (2006) 349(3):875-82. doi:10.1016/j.bbrc.2006.07.083.
45. Jiang MS, Lane MD. Sequential repression and activation of the CCAAT enhancer-binding protein-a (C/EBPa) gene during adipogenesis. Proc Natl Acad Sci USA (2000) 97(23):12519-23. doi:10.1073/pnas.220426097.
46. Dunnett CW. A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc (1955) 50:1096-121. doi:10.1080/0162 1459.1955.10501294.
47. Zhang XM, Verdine GL. A small region in HMGI(Y) is critical for cooperation with NF-kappaB on DNA. J Biol Chem (1999) 274(29):20235-43. doi:10.1074/jbc.274.29.20235.
48. Yun Z, Maecker HL, Johnson RS, Giaccia A. Inhibition of PPARg2 expression by the HIF-1- regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia. Dev Cell (2002) 2:331-41. doi: 10.1016/S1534-5807(02)00131-4.
49. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, et al. NF-kB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1a. Nature (2008) 453:807-11. doi:10.1038/nature06905.
50. Chen CA, Chang JT, Ho YF, Shyu AB. MiR-26 down-regulates TNF-a/NF-KB signaling and IL-6 expression by silencing HMGA1 and MALT1. Nucleic Acids Res (2016) 44(8):3772-87. doi:10.1093/nar/gkw205.
51. Wobben R, Hüsecken Y, Lodewick C, Gibbert K, Fandrey J, Winning S. Role of hypoxia inducible factor-1a for interferon synthesis in mouse dendritic cells. Biol Chem (2013) 394(4):495-505. doi:10.1515/hsz-2012-0320.
52. Carvajal IM, Baron RM, Perrella MA. High-mobility group-I/Y proteins: potential role in the pathophysiology of critical illnesses. Crit Care Med (2002) 30(1 Suppl):S36-42. doi:10.1097/00003246-200201001-00005.
53. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol (1999) 19(8):5237-46. doi:10.1128/MCB.19.8.5237.
54. Regazzetti C, Peraldi P, Grémeaux T, Najem-Lendom R, Ben-Sahra I, Cormont M, et al. Hypoxia decreases insulin signaling pathways in adipocytes. Diabetes (2009) 58(1):95-103. doi:10.2337/db08-0457.
55. Jiang C, Qu A, Matsubara T, Chanturiya T, Jou W, Gavrilova O, et al. Disruption of hypoxia-inducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet-fed mice. Diabetes (2011) 60(10):2484-95. doi:10.2337/db11-0174.
56. Chiefari E, Nevolo MT, Arcidiacono B, Maurizio E, Nocera A, Iiritano S, et al. HMGA1 is a novel downstream nuclear target of the insulin receptor signalling pathway. Sci Rep (2012) 2:251. doi:10.1038/srep00251.
57. Iiritano S, Chiefari E, Ventura V, Arcidiacono B, Possidente K, Nocera A, et al. The HMGA1-IGF-I/IGFBP system: a novel pathway for modulating glucose uptake. Mol Endocrinol (2012) 26(9):1578-89. doi:10.1210/me.2011-1379.
58. Chiefari E, Tanyolaç S, Paonessa F, Pullinger CR, Capula C, Iiritano S, et al. Functional variants of the HMGA1 gene and type 2 diabetes mellitus. JAMA (2011) 305(9):903-12. doi:10.1001/jama.2011.207.
59. Chiefari E, Tanyolaç S, Iiritano S, Sciacqua A, Capula C, Arcidiacono B, et al. A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components. Sci Rep (2013) 3:1491. doi: 10.1038/srep01491.